Seok Jin Kim

Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma

Jesús F. San Miguel, Binod Dhakal, Kwee Yong et al. · New England Journal of Medicine · 2023 · 733 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase

Yok‐Lam Kwong, Thomas S. Y. Chan, Daryl Tan et al. · Blood · 2017 · 495 citations · Full text

Life Sciences, Immunology, Oncology +14

SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group

Yok‐Lam Kwong, Won Seog Kim, Soon Thye Lim et al. · Blood · 2012 · 425 citations

Life Sciences, Immunology, Oncology +13

A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis

Seok Jin Kim, Dok Hyun Yoon, Arnaud Jaccard et al. · The Lancet Oncology · 2016 · 386 citations · Full text

Medicine, Clinical Sciences, Oncology +15

A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma

Hae Yong Yoo, Min Kyung Sung, Seung Ho Lee et al. · Nature Genetics · 2014 · 381 citations

Medicine, Molecular Genetics, Oncology +10